Header Logo

Connection

Theodore Pincus to Severity of Illness Index

This is a "connection" page, showing publications Theodore Pincus has written about Severity of Illness Index.
Connection Strength

7.858
  1. Disease Burden in Osteoarthritis Is Similar to That of Rheumatoid Arthritis at Initial Rheumatology Visit and Significantly Greater Six Months Later. Arthritis Rheumatol. 2019 08; 71(8):1276-1284.
    View in: PubMed
    Score: 0.501
  2. Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken). 2014 Jun; 66(6):934-42.
    View in: PubMed
    Score: 0.352
  3. MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol. 2013 Jun; 19(4):169-74.
    View in: PubMed
    Score: 0.329
  4. Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Feb; 65(2):288-93.
    View in: PubMed
    Score: 0.321
  5. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care. Bull NYU Hosp Jt Dis. 2012; 70 Suppl 1:30-6.
    View in: PubMed
    Score: 0.298
  6. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms. J Rheumatol. 2011 Jul; 38(7):1309-16.
    View in: PubMed
    Score: 0.283
  7. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):181-9.
    View in: PubMed
    Score: 0.261
  8. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):713-22, v-vi.
    View in: PubMed
    Score: 0.256
  9. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am. 2009 Nov; 35(4):773-8, viii.
    View in: PubMed
    Score: 0.256
  10. Is a self-report RAPID3 score a reasonable alternative to a DAS28 in usual clinical care? J Clin Rheumatol. 2009 Aug; 15(5):215-7.
    View in: PubMed
    Score: 0.252
  11. Declines in erythrocyte sedimentation rates in patients with rheumatoid arthritis over the second half of the 20th century. J Rheumatol. 2009 Aug; 36(8):1596-9.
    View in: PubMed
    Score: 0.250
  12. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care. J Rheumatol. 2009 Jun; 36(6):1099-100.
    View in: PubMed
    Score: 0.249
  13. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008 Nov; 35(11):2136-47.
    View in: PubMed
    Score: 0.237
  14. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol. 2008 Apr; 35(4):603-9.
    View in: PubMed
    Score: 0.228
  15. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol. 2006 Nov; 33(11):2146-52.
    View in: PubMed
    Score: 0.208
  16. The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis. J Rheumatol. 2006 May; 33(5):834-7.
    View in: PubMed
    Score: 0.201
  17. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum. 2005 Apr; 52(4):1031-6.
    View in: PubMed
    Score: 0.187
  18. HAQ and DAS28 for clinical trials over months and MDHAQ, RheuMetric and psycho-socio-economic measures for long-term observations over years? Rheumatology (Oxford). 2022 10 06; 61(10):3884-3886.
    View in: PubMed
    Score: 0.157
  19. Further Simplified Clinimetry Using a Multidimensional Health Assessment Questionnaire. J Rheumatol. 2023 03; 50(3):460.
    View in: PubMed
    Score: 0.157
  20. Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease. Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):7-17.
    View in: PubMed
    Score: 0.128
  21. Fibromyalgia Assessment Screening Tool: Clues to Fibromyalgia on a Multidimensional Health Assessment Questionnaire for Routine Care. J Rheumatol. 2020 05 01; 47(5):761-769.
    View in: PubMed
    Score: 0.127
  22. Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis. J Rheumatol. 2019 01; 46(1):27-30.
    View in: PubMed
    Score: 0.119
  23. Update on imaging in rheumatic diseases. Clin Exp Rheumatol. 2018 Sep-Oct; 36 Suppl 114(5):2.
    View in: PubMed
    Score: 0.119
  24. Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):S49-S53.
    View in: PubMed
    Score: 0.104
  25. Information technology in rheumatology. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):1.
    View in: PubMed
    Score: 0.104
  26. Pragmatic assessment of exercise in routine care using an MDHAQ: associations with changes in RAPID3 and other clinical variables. Arthritis Res Ther. 2016 09 06; 18:199.
    View in: PubMed
    Score: 0.103
  27. RheuMetric A Physician Checklist to Record Patient Levels of Inflammation, Damage and Distress as Quantitative Data Rather than as Narrative Impressions. Bull Hosp Jt Dis (2013). 2015 Jul; 73(3):178-84.
    View in: PubMed
    Score: 0.095
  28. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care. Bull Hosp Jt Dis (2013). 2014; 72(2):136-41.
    View in: PubMed
    Score: 0.086
  29. RHEUMDOC: a one-page RHEUMatology DOCtor form with four physician global estimates for overall status, inflammation, damage, and symptoms based on neither inflammation nor damage. Bull Hosp Jt Dis (2013). 2014; 72(2):142-7.
    View in: PubMed
    Score: 0.086
  30. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort. J Rheumatol. 2013 Apr; 40(4):386-93.
    View in: PubMed
    Score: 0.080
  31. Treat-to-target: not as simple as it appears. Clin Exp Rheumatol. 2012 Jul-Aug; 30(4 Suppl 73):S10-20.
    View in: PubMed
    Score: 0.079
  32. An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Bull NYU Hosp Jt Dis. 2012; 70(2):73-94.
    View in: PubMed
    Score: 0.074
  33. MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Bull NYU Hosp Jt Dis. 2012; 70(3):177-86.
    View in: PubMed
    Score: 0.074
  34. Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ). Bull NYU Hosp Jt Dis. 2012; 70 Suppl 1:14-20.
    View in: PubMed
    Score: 0.074
  35. Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care. Bull NYU Hosp Jt Dis. 2011; 69(2):104-10.
    View in: PubMed
    Score: 0.070
  36. MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis. 2011; 69(3):201-14.
    View in: PubMed
    Score: 0.070
  37. In the clinic. Rheumatoid arthritis. Ann Intern Med. 2010 Jul 06; 153(1):ITC1-1-ITC1-15; quiz ITC1-16.
    View in: PubMed
    Score: 0.067
  38. Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis. 2010; 68(2):130-9.
    View in: PubMed
    Score: 0.065
  39. Beyond RAPID3 - practical use of the MDHAQ to improve doctor-patient communication. Bull NYU Hosp Jt Dis. 2010; 68(3):223-31.
    View in: PubMed
    Score: 0.065
  40. The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care. Rheum Dis Clin North Am. 2009 Nov; 35(4):787-98, ix.
    View in: PubMed
    Score: 0.064
  41. How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQ. Rheum Dis Clin North Am. 2009 Nov; 35(4):799-812, x.
    View in: PubMed
    Score: 0.064
  42. A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am. 2009 Nov; 35(4):819-27, x.
    View in: PubMed
    Score: 0.064
  43. Flowsheets that include MDHAQ physical function, pain, global, and RAPID3 scores, laboratory tests, and medications to monitor patients with all rheumatic diseases: an electronic database for an electronic medical record. Rheum Dis Clin North Am. 2009 Nov; 35(4):829-42, x-xi.
    View in: PubMed
    Score: 0.064
  44. Management of associated rheumatoid arthritis and fibromyalgia. J Rheumatol. 2009 Sep; 36(9):2123-4; discussion 2124-5.
    View in: PubMed
    Score: 0.063
  45. RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases. Bull NYU Hosp Jt Dis. 2009; 67(2):211-25.
    View in: PubMed
    Score: 0.061
  46. Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008 Aug; 35(8):1550-8.
    View in: PubMed
    Score: 0.058
  47. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2008; 66(3):216-23.
    View in: PubMed
    Score: 0.056
  48. Quantitative measures to assess patients with rheumatic diseases: 2006 update. Rheum Dis Clin North Am. 2006 Dec; 32 Suppl 1:29-36.
    View in: PubMed
    Score: 0.052
  49. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum. 2006 Oct; 54(10):3113-8.
    View in: PubMed
    Score: 0.052
  50. Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires. Bull NYU Hosp Jt Dis. 2006; 64(1-2):32-9.
    View in: PubMed
    Score: 0.049
  51. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2006; 8(6):R186.
    View in: PubMed
    Score: 0.049
  52. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Arthritis Rheum. 2005 Dec; 52(12):3873-9.
    View in: PubMed
    Score: 0.049
  53. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum. 2005 Apr; 52(4):1009-19.
    View in: PubMed
    Score: 0.047
  54. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum. 2003 Feb; 48(2):313-8.
    View in: PubMed
    Score: 0.040
  55. Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight-Control Clinical Trial and an Observational Cohort. Arthritis Care Res (Hoboken). 2018 08; 70(8):1198-1205.
    View in: PubMed
    Score: 0.029
  56. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate. Rheumatology (Oxford). 2013 Oct; 52(10):1890-7.
    View in: PubMed
    Score: 0.021
  57. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011 Mar; 70(3):404-13.
    View in: PubMed
    Score: 0.018
  58. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011 Mar; 63(3):573-86.
    View in: PubMed
    Score: 0.018
  59. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep; 69(9):1580-8.
    View in: PubMed
    Score: 0.017
  60. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep; 62(9):2569-81.
    View in: PubMed
    Score: 0.017
  61. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 2010 Aug 01; 37(8):1633-8.
    View in: PubMed
    Score: 0.017
  62. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease. Respir Med. 2010 Sep; 104(9):1350-5.
    View in: PubMed
    Score: 0.017
  63. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther. 2010; 12(2):R42.
    View in: PubMed
    Score: 0.016
  64. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009; 11(1):R7.
    View in: PubMed
    Score: 0.015
  65. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum. 2008 Sep; 58(9):2642-51.
    View in: PubMed
    Score: 0.015
  66. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum. 2008 Sep; 58(9):2662-9.
    View in: PubMed
    Score: 0.015
  67. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol. 2007 Dec; 34(12):2388-94.
    View in: PubMed
    Score: 0.014
  68. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007 Nov; 66(11):1491-6.
    View in: PubMed
    Score: 0.013
  69. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005 Oct; 52(10):3045-53.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.